Talat Imran

Insider Reports History

Entity
Individual
Location
C/O Rani Therapeutics Holdings, Inc., 2051 Ringwood Avenue, San Jose, CA
Signature
Talat Imran
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Talat Imran:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Rani Therapeutics Holdings, Inc. Chief Executive Officer, Director Class A Common Stock 484K $1.1M $2.27 Dec 6, 2023 Direct
Rani Therapeutics Holdings, Inc. Chief Executive Officer, Director Stock Option (Right to Buy) 1.09M Mar 21, 2024 Direct
Rani Therapeutics Holdings, Inc. Chief Executive Officer, Director 271875 272K Dec 16, 2023 Direct

Insider Reports Filed by Talat Imran

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RANI Rani Therapeutics Holdings, Inc. Mar 21, 2024 1 $0 4 Mar 22, 2024 Chief Executive Officer, Director
RANI Rani Therapeutics Holdings, Inc. Dec 16, 2023 8 $0 4 Dec 19, 2023 Chief Executive Officer, Director
RANI Rani Therapeutics Holdings, Inc. Dec 6, 2023 1 $22.7K 4 Dec 7, 2023 Chief Executive Officer, Director
RANI Rani Therapeutics Holdings, Inc. Dec 4, 2023 1 $12.9K 4 Dec 6, 2023 Chief Executive Officer, Director
RANI Rani Therapeutics Holdings, Inc. Nov 29, 2023 1 $41K 4 Dec 1, 2023 Chief Executive Officer, Director
RANI Rani Therapeutics Holdings, Inc. Nov 7, 2023 2 $9.98K 4 Nov 9, 2023 Chief Executive Officer, Director
RANI Rani Therapeutics Holdings, Inc. Mar 27, 2023 2 $0 4 Mar 29, 2023 CEO, Director
RANI Rani Therapeutics Holdings, Inc. Mar 22, 2023 1 -$47.5K 4 Mar 24, 2023 CEO, Director
RANI Rani Therapeutics Holdings, Inc. Mar 22, 2022 2 $0 4 Mar 24, 2022 Chief Executive Officer, Director
RANI Rani Therapeutics Holdings, Inc. Feb 3, 2022 2 $0 4 Feb 7, 2022 Chief Executive Officer, Director
RANI Rani Therapeutics Holdings, Inc. Sep 9, 2021 1 $0 4 Sep 13, 2021 Chief Executive Officer, Director
RANI Rani Therapeutics Holdings, Inc. Jul 29, 2021 0 $0 3/A Aug 2, 2021 Chief Executive Officer, Director